Corvus Pharmaceuticals publishes final Phase 1 Soquelitinib data in Blood
Corvus Pharmaceuticals says final Phase 1 data from its Soquelitinib Phase 1/1b T cell lymphoma trial was published in Blood.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.